Abstract
Type 2 diabetes (T2D) and obesity represent growing public health challenges, strongly associated with insulin resistance. Recent studies point to the gut microbiota as a determining factor in this process, as intestinal dysbiosis can promote metainflammation in visceral adipose tissue (VAT), intestinal permeability, and, consequently, the development of T2D. In this scenario, prebiotics …